NASDAQ: CDTX
Cidara Therapeutics Inc Stock Ownership - Who owns Cidara Therapeutics?

Insider buying vs selling

Have Cidara Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Leslie TariCHIEF SCIENTIFIC OFFICER2025-03-111,773$21.96
$38.94kSell
Shane WardCOO CLO2025-03-111,664$21.96
$36.54kSell
Ra Capital Management LPDirector2024-11-26389,716$14.91
$5.81MBuy
Taylor SandisonChief Medical Officer2024-09-11924$11.64
$10.75kSell
Leslie TariCHIEF SCIENTIFIC OFFICER2024-09-11909$11.64
$10.58kSell
Jeffrey SteinPresident CEO2024-06-078,000$13.21
$105.68kBuy

1 of 1

CDTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CDTX insiders and whales buy or sell their stock.

CDTX Shareholders

What type of owners hold Cidara Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ag Mundipharma36.87%4,781,408$89.08MInsider
Target N. V. Biotech17.70%2,295,272$42.76MInsider
Nina S. Kjellson10.46%1,356,813$25.28MInsider
Bvf Inc8.43%1,092,796$20.36MInstitution
Ra Capital Management LP8.43%1,092,796$20.36MInsider
Ra Capital Management LP8.43%1,092,796$20.36MInstitution
Steve Elms8.13%1,054,610$19.65MInsider
Tcg Crossover Management LLC7.76%1,005,901$18.74MInstitution
Vr Adviser LLC5.90%765,723$14.27MInstitution
Aisling Capital II LP5.42%703,092$13.10MInsider

1 of 3

CDTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CDTX34.46%65.54%Net BuyingNet Selling
NGNE47.44%52.56%Net BuyingNet Selling
AVIR65.74%25.15%Net Selling
GOSS75.40%14.63%Net Buying
ALLO70.67%29.33%Net BuyingNet Selling

Cidara Therapeutics Stock Ownership FAQ

Who owns Cidara Therapeutics?

Cidara Therapeutics (NASDAQ: CDTX) is owned by 53.00% institutional shareholders, 100.80% Cidara Therapeutics insiders, and 0.00% retail investors. Ag Mundipharma is the largest individual Cidara Therapeutics shareholder, owning 4.78M shares representing 36.87% of the company. Ag Mundipharma's Cidara Therapeutics shares are currently valued at $92.90M.

If you're new to stock investing, here's how to buy Cidara Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.